Pancreatic Cancer Research

ResearcherHirosaki UniversityNo recent work listed

Daisuke Kudo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8213-5176; OpenAlex author ID A5013445506. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: 1 paper

Papers 8

  1. Increase of Tumor Infiltrating γδ T-cells in Pancreatic Ductal Adenocarcinoma Through Remodeling of the Extracellular Matrix by a Hyaluronan Synthesis Suppress… First author DOI 10.1097/mpa.0000000000001211↗
  2. [A Case of Remnant Pancreatic Cancer after Conversion Surgery for Advanced Distal Bile Duct Cancer Treated with Chemotherapy]. Co-author PMID 30692392↗
  3. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells. First author DOI 10.1097/mpa.0000000000000741↗
  4. The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms18030600↗
  5. Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer. Co-author DOI 10.3892/mco.2017.1251↗
  6. Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer. First author DOI 10.3892/ol.2016.4930↗
  7. [Study of unresectable pancreatic cancer - successful resections after gemcitabine-based chemotherapy]. Co-author PMID 24393952↗
  8. Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer. Co-author DOI 10.3892/ol.2011.412↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenichi Hakamada · 8 shared papers, 2011–2019 · strength 0.58
  2. Akiko Suto · 3 shared papers, 2017–2019 · strength 0.29
  3. Hayato Nagase · 3 shared papers, 2016–2019 · strength 0.23
  4. Eri Yoshida · 3 shared papers, 2016–2019 · strength 0.23
  5. Keinosuke Ishido · 4 shared papers, 2011–2018 · strength 0.23
  6. Shingo Sakuraba · 2 shared papers, 2013–2018 · strength 0.13
  7. Taiichi Wakiya · 2 shared papers, 2013–2017 · strength 0.12
  8. Yusuke Wakasa · 1 shared paper, 2018 · strength 0.09
  9. Takeshi Saito · 1 shared paper, 2017 · strength 0.08
  10. Shinji Tsutsumi · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.